Literature DB >> 3002691

Analysis of T cell activation with a non-mitogenic anti CD3 antibody and the phorbol ester TPA.

W Holter, O Majdic, H Stockinger, W Knapp.   

Abstract

We used a non mitogenic anti CD3 antibody, termed VIT3, to study the signals required for the activation of normal resting T lymphocytes. Besides being not mitogenic, this antibody completely inhibits mitogen induced proliferative responses. In the presence of the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA), however, VIT3 induces DNA replication and cell proliferation comparable to PHA responses. In addition, T cells cultured with VIT3 plus TPA but not with VIT3 or TPA alone express high levels of interleukin 2 (IL-2) receptors and transferrin receptors. This co-stimulation appears to be accessory cell independent. Purified T cells respond equally well to VIT3 plus TPA as do unseparated mononuclear cells and addition of non-T cells has no enhancing effect. We conclude that the IgM antibody VIT3, although non-mitogenic by itself, still delivers a first and for the activation essential signal. In resting T cells this signal does not induce demonstrable anti-Tac antibody binding nor does it lead to a fully developed proliferative response in the presence of recombinant IL-2. Together with a second signal provided by TPA it serves, however, as a potent inducer of T cell growth.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3002691      PMCID: PMC1577494     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Signal requirements for T lymphocyte activation. I. Replacement of macrophage function with phorbol myristic acetate.

Authors:  D L Rosenstreich; S B Mizel
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Monoclonal antibodies defining distinctive human T cell surface antigens.

Authors:  P Kung; G Goldstein; E L Reinherz; S F Schlossman
Journal:  Science       Date:  1979-10-19       Impact factor: 47.728

3.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

4.  OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties.

Authors:  J P Van Wauwe; J R De Mey; J G Goossens
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

5.  Macrophage-independent activation of helper T cells. I. Production of Interleukin 2.

Authors:  J J Farrar; S B Mizel; J Fuller-Farrar; W L Farrar; M L Hilfiker
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

6.  A monoclonal antibody blocking human T cell function.

Authors:  E L Reinherz; R E Hussey; S F Schlossman
Journal:  Eur J Immunol       Date:  1980-10       Impact factor: 5.532

7.  Monoclonal antibodies to human myelomonocyte differentiation antigens in the diagnosis of acute myeloid leukemia.

Authors:  W Knapp; O Majdic; H Stockinger; P Bettelheim; K Liszka; U Köller; C Peschel
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

8.  Novel surface antigen expressed on dividing cells but absent from nondividing cells.

Authors:  W Judd; C A Poodry; J L Strominger
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

9.  Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation.

Authors:  J L Touraine; J W Hadden; F Touraine; E M Hadden; R Estensen; R A Good
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

10.  Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.

Authors:  S Gillis; J Watson
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  10 in total

1.  Phenotypic changes associated with activation of CD45RA+ and CD45RO+ T cells.

Authors:  D L Wallace; P C Beverley
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

2.  Induction of interleukin 2 receptiveness and proliferation in resting peripheral T cells by monoclonal anti-CD3 (T3) antibodies does not require the presence of macrophages.

Authors:  L A Stingl; A Sinska; U Landesmann; J S Smolen
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

3.  Interleukin 3 activates human blood basophils via high-affinity binding sites.

Authors:  P Valent; J Besemer; M Muhm; O Majdic; K Lechner; P Bettelheim
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

4.  Expression of HRF20, a regulatory molecule of complement activation, on peripheral blood mononuclear cells.

Authors:  T Hideshima; N Okada; H Okada
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

5.  Mitogenic action of phorbol ester TPA and calcium ionophore A23187 on human cord and maternal/adult peripheral lymphocytes: regulation by prostaglandin E2.

Authors:  N Papadogiannakis; S A Johnsen
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

6.  Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes.

Authors:  M Cebrián; E Yagüe; M Rincón; M López-Botet; M O de Landázuri; F Sánchez-Madrid
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

7.  T-cell functionality testing is highly relevant to developing novel immuno-tracers monitoring T cells in the context of immunotherapies and revealed CD7 as an attractive target.

Authors:  Kristine E Mayer; Sabine Mall; Nahid Yusufi; Dario Gosmann; Katja Steiger; Lisa Russelli; Henrique de Oliviera Bianchi; Stefan Audehm; Ricarda Wagner; Eva Bräunlein; Anja Stelzl; Florian Bassermann; Wilko Weichert; Wolfgang Weber; Markus Schwaiger; Calogero D'Alessandria; Angela M Krackhardt
Journal:  Theranostics       Date:  2018-11-28       Impact factor: 11.556

8.  T cell stimulation via the erythrocyte receptor. Synergism between monoclonal antibodies and phorbol myristate acetate without changes of free cytoplasmic Ca++ levels.

Authors:  W Holter; G F Fischer; O Majdic; H Stockinger; W Knapp
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

9.  Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens, and antigens.

Authors:  T Hara; L K Jung; J M Bjorndahl; S M Fu
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

10.  Transferrin receptor 1 is a cellular receptor for human heme-albumin.

Authors:  Brell Jennifer; Verena Berg; Madhura Modak; Alexander Puck; Maria Seyerl-Jiresch; Sarojinidevi Künig; Gerhard J Zlabinger; Peter Steinberger; Janet Chou; Raif S Geha; Leopold Öhler; Akihiro Yachie; Hyeryun Choe; Markus Kraller; Hannes Stockinger; Johannes Stöckl
Journal:  Commun Biol       Date:  2020-10-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.